Listed

BioCardia, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Oct 29, 2015 and accepted by EDGAR at Oct 29, 2015, 16:51 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2015-07-01 to 2015-09-30$83.0kus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30$230.0kus-gaap:OperatingIncomeLoss
Income tax3 months2015-07-01 to 2015-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2015-01-01 to 2015-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-07-01 to 2015-09-30$83.0kus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30$232.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)3 months2015-07-01 to 2015-09-30230,293,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2015-01-01 to 2015-09-30230,293,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2015-01-01 to 2015-09-30$217.0kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2015-09-30$13.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2015-09-30$13.8mus-gaap:Assets
Total liabilitiesAt period end2015-09-30$0us-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$13.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001136261-15-000302. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.